Skip Navigation
Skip to contents

ICKSH 2025

END 2025-06-07

Invited Speakers

Home

PROGRAM
Invited Speakers
Search

Day 3: March 29 (Sat)

[JS05] Joint Session 05 (Asia Session): MRD and Immunotherapy in Multiple Myeloma: Collaborative Insights from Korea and Japan Day 3: March 29 (Sat), 09:00-10:15 | Room 1
  • Current status of MRD assessment in Japan Hiroyuki Takamatsu
    Kanazawa University, Japan     CV Abstract
  • Current status of MRD assessment in Korea Saeam Shin
    Yonsei University College of Medicine, Korea     CV Abstract
  • Advances in the treatment for RRMM using CAR-T and bispecific antibodies Tadao Ishida
    Japanese Red Cross Medical Center, Japan     CV Abstract
  • Real-world efficacy and safety of teclistamab for patients with released or refractory multiple myeloma: Korean, nationwide, retrospective analysis Jun Ho Yi
    Chung-Ang University College of Medicine, Korea     CV Abstract

Day 3: March 29 (Sat)

[SS14] Scientific Session 14: Deciphering Blood Coagulation Tests Day 3: March 29 (Sat), 09:00-10:15 | Room 2
  • Investigative approaches to unexplained bleeding Alessandro Casini
    University Hospitals of Geneva, Switzerland     CV Abstract
  • Optimal testing strategies for suspected platelet disorders Christopher Ward
    University of Sydney, Australia     CV Abstract
  • Thrombophilia testing in clinical practice: Indications, challenges, and current approaches Hee-Jin Kim
    Sungkyunkwan University School of Medicine, Korea     CV Abstract

Day 3: March 29 (Sat)

[SS15] Scientific Session 15: Immunotherapy in B-Cell Lymphoma: Current Status and Emerging Approaches Day 3: March 29 (Sat), 09:00-10:15 | Room 3
  • Advancing CD3xCD20 bispecific Abs: Integration in first-line treatment of DLBCL  Catherine Thieblemont
    Hôpital Saint-Louis, France     CV
  • Antibody based treatments for B-cell Lymphoma: New targets and future directions Youngil Koh
    Seoul National University College of Medicine, Korea     CV Abstract
  • Management of toxicity of bispecific antibody for B-cell lymphomas Koji Izutsu
    National Cancer Center Hospital, Japan     CV Abstract

Day 3: March 29 (Sat)

[ES08] Education Session 08: Supportive Care: Management of Infections and Iron Overload Day 3: March 29 (Sat), 09:00-10:15 | Room 4
  • Invasive fungal infections in hematologic disease: Prophylaxis and treatment Sung-Yeon Cho
    College of Medicine, The Catholic University of Korea, Korea     CV Abstract
  • CMV infections after HSCT: Prophylaxis and treatment Haerim Chung
    Yonsei University College of Medicine, Korea     CV Abstract
  • Iron overload and iron chelation therapy Ga-Young Song
    Chonnam National University Medical School, Korea     CV Abstract

Day 3: March 29 (Sat)

[PL03] Plenary Lecture 03 Day 3: March 29 (Sat), 10:30-11:15 | Room 1+2
  • New discoveries that will shape future therapies in Chronic Myeloid Leukemia Timothy Hughes
    South Australian Health and Medical Research Institute (SAHMRI), Australia     CV Abstract